3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Brand Engagement Network Inc. entered a settlement agreement with Evora Partners on September 30, 2026, to resolve about $1.3 million it owed under a January 2021 consulting agreement. Evora agreed to accept $825,000, including a $75,000 reimbursement of attorneys' fees, and will dismiss its pending lawsuit against the company. The deal resolves a liability already recorded in accounts payable and removes the pending litigation.
Settlement amount is $825,000, including a $75,000 reimbursement of Evora's attorneys' fees, against about $1.3 million owed.
The company has paid $175,000; the remaining $650,000 is due in installments through December 2026, guaranteed by BEN Capital Fund I, LLC.
Evora will dismiss its lawsuit filed September 2, 2026, in the U.S. District Court for the Southern District of New York.
Firy Inc., formerly Skillz Inc., completed the redemption of all $49,671,000 in principal of its 10.250% Secured Notes due 2026 on October 15, 2026, at 100% of principal plus accrued and unpaid interest. No Notes remain outstanding after the redemption, which removes this secured debt from the company's obligations.
Redeemed all $49,671,000 aggregate principal amount of 10.250% Secured Notes due 2026
Redemption price was 100.000% of principal, plus accrued and unpaid interest to the redemption date
No Notes remain outstanding following the October 15, 2026 redemption
Select Water Holdings LLC, a subsidiary of Select Water Solutions, priced $900 million of 7.625% senior notes maturing November 1, 2034, upsized from $800 million and sold at par, with closing expected October 21, 2026. Net proceeds of approximately $882.6 million, plus cash on hand, will fund part of the cash consideration for the pending Pilot Water Solutions acquisition and repay the term loan and revolving credit facility obligations. The notes add $900 million of debt, and if the Pilot Water Acquisition is not completed by March 1, 2027, most of the notes must be redeemed.
$900 million of 7.625% senior notes due November 1, 2034, upsized from $800 million and priced at par
Approximately $882.6 million in net proceeds after the initial purchasers' discount and estimated offering expenses; closing expected October 21, 2026
Proceeds fund part of the Pilot Water Acquisition cash consideration and repay the term loan in full
If the Pilot Water Acquisition is not completed by March 1, 2027, the issuer must redeem notes equal to the principal less $450 million
Northrim BanCorp reported third-quarter 2026 net income of $14.4 million, or $0.63 per diluted share, down from $27.1 million, or $1.20 per share, a year earlier. The results include an $8.8 million impairment on a single $20.0 million loan relationship at Northrim Funding Services, which the company expects to reduce after-tax earnings by $6.7 million, or $0.29 per diluted share, and it says resolution will take several quarters.
Q3 2026 net income $14.4 million ($0.63 per diluted share), versus $15.3 million ($0.68) in Q2 2026 and $27.1 million ($1.20) in Q3 2025
Impairment charge of $8.8 million tied to one $20.0 million relationship; after-tax effect of about $6.7 million or $0.29 per diluted share
Net interest income rose 5% from the prior quarter to $38.9 million and 10% from a year earlier
Proposed PBCO Financial acquisition, all-stock, expected to close in the first quarter of 2027
FG Communities Holdings Inc. closed two manufactured housing community acquisitions in North Carolina: one in Garner on October 8, 2026, and one in Mars Hill on October 9, 2026. Both sellers are unaffiliated third parties, and the company paid for both with cash on hand. The filing does not disclose purchase prices, so the deals' financial effect on shareholders cannot be measured from this document.
Garner, NC community closed October 8, 2026: 49 homesites on 59 acres, paid with cash on hand
Mars Hill, NC community closed October 9, 2026: 29 homesites on 19 acres, paid with cash on hand
Both sellers are unaffiliated third parties
The filing does not disclose purchase prices; press releases dated October 12 and October 15, 2026 announced the deals
Opus Genetics presented interim clinical data from its OPGx-BEST1 and OPGx-LCA5 gene therapy trials at Retina in Rio 2026 on October 14, 2026, and furnished the press release and slides in this 8-K. The company said the data are interim and based on small participant groups, and it expects Phase 3 dosing for OPGx-LCA5 to begin in the fourth quarter of 2026.
OPGx-BEST1 low-dose Cohort 1: three of four evaluable participants (75%) showed improved retinal sensitivity in the treated transitional zone.
OPGx-LCA5 adults showed sustained improvements in visual acuity and light sensitivity through 24 months; three pediatric participants showed results through six months.
OPGx-BEST1 high-dose Cohort 2 has completed enrollment with 11 participants.
Phase 3 dosing for OPGx-LCA5 is expected in the fourth quarter of 2026.
Mount Logan Capital's indirect subsidiary MLC US Holdings signed Amendment No. 6 to its credit agreement, which waives certain specified defaults linked to the September 29, 2026 merger of Alternative Credit Income Fund into BC Partners Lending Corporation and the cancellation of a $15.0 million promissory note. The filing also discloses a revenue share agreement that gives the subsidiary a share of adviser fees, but it does not report any financial results or a dollar amount for that share.
Amendment No. 6 dated October 9, 2026 includes a limited waiver of specified events of default under the Credit Agreement.
The SCIM Promissory Note, originally $15.0 million, was cancelled on September 29, 2026 in exchange for rights to a 29.88% revenue share of BCPA's management and incentive fees, less certain sales force compensation.
Net amount owed to Sierra Crest Investment Management under the terminated Services Agreement was initially calculated at approximately $3.4 million, to be repaid quarterly by offset against revenue share payments.
No early termination penalties were incurred in connection with the note cancellation or the Services Agreement termination.
Varonis Systems agreed to be acquired by Proofpoint, a Thoma Bravo portfolio company, in an all-cash transaction valued at about $6.3 billion. Varonis shareholders would receive $49.75 per share, a 52% premium to the June 22, 2026 closing price of $32.71, and the deal requires shareholder and regulatory approval, with closing expected in the first half of 2027. Varonis shares would stop trading on Nasdaq and the company would become private.
Merger consideration of $49.75 per share in cash, a 52% premium to the $32.71 close on June 22, 2026 and 17% above the $42.35 close on September 1, 2026
Transaction valued at about $6.3 billion, or about 53x LTM free cash flow and 8.4x LTM revenue
Varonis must pay Proofpoint a $211.7 million termination fee in specified circumstances; Proofpoint would pay a $423.3 million reverse termination fee in specified circumstances
Expected to close in the first half of 2027; either party may terminate if the merger is not completed by July 15, 2027, subject to a three-month regulatory extension
Biohaven entered into a Collaboration and License Agreement with Ono Pharmaceutical dated October 8, 2026, granting Ono an exclusive, royalty-bearing license to develop and commercialize its MoDE pan IgG degrader portfolio in Japan, South Korea, Taiwan and the ASEAN countries. Biohaven retains rights outside that territory, including the United States, Europe and China. The deal provides Biohaven up to $100 million in near-term payments, which the company says is non-dilutive capital.
Ono pays a one-time, non-refundable upfront payment of $80 million upon closing.
Biohaven is eligible for another $20 million upon a milestone, tied to Ono's stability test results and its election to continue development; the press release anticipates this milestone within a year.
Ono will pay royalties of approximately 20% on net sales of licensed products in the licensed territory, subject to specified reductions.
Ono may terminate the agreement for convenience on specified prior written notice, in whole or by product or country.
Cenntro Inc. entered into a sales agreement dated October 9, 2026, with Pacific Century Securities, LLC, allowing it to sell up to $100 million of common stock through the agent over time. The company is not obligated to sell any shares, and the agent has no obligation to buy shares on its own account, so the actual amount raised is not set. Shareholders could face dilution if the company sells shares under the program.
Sales agreement dated October 9, 2026, covers up to $100,000,000 of common stock at the market.
Pacific Century Securities, LLC receives a 3.5% commission on gross proceeds from each sale.
Shares are offered under a prospectus supplement dated October 9, 2026, filed October 13, 2026, on Form S-3 effective February 12, 2026.
The company paid $50,000 at signing under an engagement letter dated September 1, 2026, with up to $50,000 more due at the first placement closing.
SPACSphere Acquisition Corp. and Mobilewalla signed an amendment to their Business Combination Agreement that would expand the combined company's board from five to seven directors, effective at closing of the merger. The amendment sets out who would hold the seats, including two Mobilewalla designees, one SPACSphere designee and four independent directors, and the rest of the original agreement remains in effect.
Combined company board would grow from five to seven directors, effective at the merger closing
Mobilewalla designees: Anindya Datta (Class III) and Boris M. Gutin; SPACSphere designee: Bala Padmakumar
Four independent directors, including George Brody, John Garner and Stephen Markscheid; the fourth will be appointed before the Form S-4 is declared effective
ChronoScale Holdings reported fiscal first quarter 2027 revenue of $41.5 million, up 148% from a year earlier, driven by a new customer's AI infrastructure hardware resale arrangements. Net loss from continuing operations widened to $26.4 million, or $0.18 per share, from $11.2 million, or $0.08 per share, and Adjusted EBITDA fell to $5.9 million from $9.4 million, so shareholders face higher losses even as sales grew.
Revenue was $41.5 million versus $16.7 million in the prior-year quarter, up 148%.
Net loss from continuing operations was $26.4 million, or $0.18 per share, compared with $11.2 million, or $0.08 per share.
Total net loss was $42.5 million, including a $16.1 million loss from discontinued operations tied to the Legacy Ekso Business, which was sold on September 30, 2026.
As of August 31, 2026, cash and cash equivalents were $15.2 million; the company reported $328.2 million in aggregate customer prepayments received after quarter end.
Actinium Pharmaceuticals said Matt David, M.D., began serving as chief financial officer on October 14, 2026, succeeding no one named in the filing. He previously was chief financial officer of CorMedix Inc. and will lead finance, accounting, capital markets and investor relations.
Dr. David commenced service as CFO and principal financial officer on October 14, 2026, under an offer letter dated September 30, 2026.
Offer terms include a $450,000 annual base salary, a 40% target annual bonus, and a $150,000 sign-on bonus.
He received an option on 250,000 shares and 325,000 restricted stock units under the 2026 Employment Inducement Award Plan, adopted by the Board on September 2, 2026 without stockholder approval.
On October 15, 2026, Pine Tree Acquisition Corp., a Cayman Islands blank check company, completed the sale of 600,000 units at $10.00 each under a partial exercise of the over-allotment option granted to Maxim Group LLC, for gross proceeds of $6,000,000. The company also issued 24,000 Ordinary Shares to an entity designated by Maxim, and $106,000,000 of IPO and private placement net proceeds was held in trust for public shareholders as of October 15, 2026.
600,000 units sold at $10.00 per unit, for gross proceeds of $6,000,000
Each unit includes one Class A ordinary share and one right to receive three-fourths of one share upon completion of an initial business combination
24,000 Ordinary Shares issued to an entity designated by Maxim Group LLC
$106,000,000 of net proceeds from the IPO and concurrent private placement deposited in trust as of October 15, 2026
Enerpac Tool Group approved a long-term incentive program on October 13, 2026, granting performance-vesting stock awards to four named executive officers linked to its previously announced acquisition of Specialized Fabrication Equipment Group LLC (SFE Group). The awards vest based on fiscal 2028 net sales and adjusted EBITDA, and are forfeited if the acquisition does not close by November 30, 2026.
Named executive awards at target level total $510,000: Darren M. Kozik $200,000, Benjamin J. Topercer $125,000, Noah N. Popp $110,000, Eric T. Chack $75,000.
Half of each award depends on net sales goals and half on adjusted EBITDA goals for fiscal 2028; payout ranges from 0% at threshold to 200% at maximum.
All awards under the program are forfeited for no consideration if the SFE Group acquisition does not close on or before November 30, 2026.
Olema Pharmaceuticals director Dr. Gorjan Hrustanovic resigned from the board effective October 14, 2026, and from the Compensation and Science and Technology committees. The company said the resignation was not due to any disagreement over its operations, policies or practices. On October 15, 2026, the board appointed Dr. Prakash Raman to the Compensation and Science and Technology committees.
Dr. Gorjan Hrustanovic gave notice on October 12, 2026 and resigned from the board effective October 14, 2026
He also left the Compensation Committee and the Science and Technology Committee
The company said the resignation involved no disagreement on operations, policies or practices
Dr. Prakash Raman was appointed to the Compensation and Science and Technology committees effective October 15, 2026
Tianci International subsidiaries agreed on October 12, 2026 to have Linknex Limited, a Hong Kong company, build an enterprise AI integration platform for their businesses. Payment will combine $146,700 in cash with 180,000 newly issued Tianci common shares, to be issued within twenty business days after the shares are listed on Nasdaq, so the deal adds a share issuance that could dilute existing holders.
Agreement dated October 12, 2026 between subsidiaries RQS United Group Limited and Roshing International Co., Limited and Linknex Limited
Consideration: $146,700 in cash plus 180,000 shares of Tianci common stock
Shares to be issued within twenty business days after listing on Nasdaq
A Statement of Work with scope, milestones and acceptance criteria is yet to be signed
Biomerica director David Moatazedi told the board on October 12, 2026 that he will not stand for re-election at the company's 2026 Annual Meeting of Stockholders, scheduled for December 11, 2026. The company said the decision was not the result of any dispute or disagreement with the company or the board. Moatazedi has served on the board since December 2022 and chairs the Compensation Committee.
Moatazedi informed the board on October 12, 2026 of his decision not to seek re-election
The 2026 Annual Meeting of Stockholders is set for December 11, 2026
Moatazedi chairs the Compensation Committee and also serves on the Nominating and Corporate Governance and Audit Committees
The filing states the departure was not due to any dispute or disagreement with the company or the board
On October 14, 2026, ALX Oncology entered into exchange agreements under which certain stockholders surrendered 13,353,384 shares of common stock to the company in return for pre-funded warrants to buy the same number of shares. The exchange is expected to settle on or about October 15, 2026, and the filing does not state any cash proceeds to the company, so the change affects the form of the holdings rather than the company's cash position as described.
Stockholders surrendered 13,353,384 common shares in exchange for pre-funded warrants for the same number of shares.
Blackstone Annex Master Fund L.P. affiliates accounted for 12,885,891 shares; RA Capital Healthcare Fund, L.P. for 213,667 shares; venBio Global Strategic Fund, L.P. for 253,826 shares.
Pre-funded warrants have an exercise price of $0.001 per share and are exercisable at any time, subject to 4.99% or 9.99% beneficial ownership limits.
Capital Southwest preliminarily estimated its results for the quarter ended September 30, 2026, which is its second quarter of fiscal 2027. The company said the estimates may change materially after its quarter-end closing procedures, so shareholders should wait for its full results on November 2, 2026.
Preliminary pre-tax net investment income estimate: $0.58 to $0.59 per share
Preliminary net investment income estimate: $0.56 to $0.57 per share
Preliminary net asset value per share as of September 30, 2026: $16.62 to $16.67
Finalized Q2 fiscal 2027 results due November 2, 2026 after market close; webcast on November 3, 2026 at 11:00 a.m. Eastern Time
Shoe Station Group entered into an amendment to its credit agreement with Wells Fargo as administrative agent, extending the $100 million revolving credit facility's maturity to October 15, 2031 and revising its pricing. The amendment also raises the annual restricted-payment basket to $40 million and permits up to $35 million of secured headquarters-related debt, giving the company more room for payments and borrowing.
Revolving credit facility of $100 million now matures October 15, 2031.
Base Rate loans carry a margin of 0.00% to 1.00%; Adjusted Term SOFR loans carry 1.00% to 2.00%, based on Consolidated Total Leverage Ratio.
Annual restricted-payment basket increased to $40 million; up to $35 million of secured debt for corporate headquarters permitted.
Amendment permits certain sale-leaseback transactions involving the Evansville, Indiana property and any corporate headquarters property.
Loop Industries reported its second quarter fiscal 2027 results for the three months ended August 31, 2026, with revenue of $117 thousand from engineering services to the India joint venture, compared with zero a year earlier. The net loss narrowed to $2.99 million from $3.20 million, and the company had total available liquidity of $1.9 million at August 31, 2026. The company also rescaled its planned India facility to 45 KTA to reduce capital needs, but its Special Committee is still seeking financing for its equity contribution.
Q2 revenue was $117 thousand, all from engineering services provided to the India JV, versus $0 in the prior-year quarter.
Net loss was $2.99 million, or $0.06 per share, versus $3.20 million, or $0.07 per share, a year earlier.
Cash operating expenses were $1.6 million, a decrease of $0.8 million year over year.
Total available liquidity was $1.9 million at August 31, 2026; the company says there can be no assurance its funding sources will be sufficient to reach commercial start-up.
Carpenter Technology said General Counsel and Secretary James D. Dee will retire effective December 31, 2026, and remain with the company through that date. The board appointed Deputy General Counsel Jed S. Freeman as Vice President, General Counsel and Secretary, effective January 1, 2027, providing a planned succession in the legal leadership role.
James D. Dee notified the company on October 12, 2026 of his decision to retire effective December 31, 2026
Jed S. Freeman, who joined the company in 2007 and is currently Deputy General Counsel, takes the role effective January 1, 2027
The company said Mr. Dee's retirement was not the result of any disagreement on operations, policies or practices
The press release announcing the change is furnished as Exhibit 99.1 under Item 7.01
Hyster-Yale's Board appointed Matthew Cornell, formerly a Stanley Black & Decker executive, as Senior Vice President and Chief Financial Officer effective November 1, 2026. CEO Rajiv K. Prasad will remain the principal financial officer until the Form 10-Q for the quarter ending September 30, 2026 is filed, after which Cornell takes over that role on November 4.
Matthew Cornell appointed SVP and CFO effective November 1, 2026
Initial base salary set at $605,000 per year, plus incentive and equity awards
Prasad serves as principal financial officer until the Q3 2026 Form 10-Q; Cornell assumes the role November 4
Cornell previously served as President and General Manager at Stanley Black & Decker from October 2022 to October 2025
Orion Group Holdings disclosed that Executive Vice President and Chief Financial Officer Alison G. Vasquez entered into a new employment agreement effective October 12, 2026, replacing her 2025 offer letter. The agreement sets a $480,000 base salary, a 75% target bonus and expanded severance terms, including enhanced payments after a change in control.
Base salary set at $480,000 per year, subject to review; target annual bonus 75% of base salary
Initial term ends December 31, 2026, renewing automatically for one-year periods
Severance without cause or for good reason: one year of salary continuation; after a change in control within 12 months, three years of salary continuation plus a lump sum of three times the most recent annual bonus
Agreement effective October 12, 2026; filed October 15, 2026, with the full text as Exhibit 10.1
Pinterest entered into an amended and restated five-year, $700 million revolving credit facility on October 15, 2026, replacing its previous $500.0 million facility from October 2022. The filing states there were no amounts outstanding under the new facility as of October 15, 2026, and that the company is in compliance with all covenants, so the agreement adds borrowing capacity without current debt.
Five-year, $700 million revolving credit facility with JPMorgan Chase Bank, N.A. as administrative agent, replacing a $500.0 million facility
Borrowings accrue at SOFR plus a 1.25% margin, or an alternative base rate plus 0.25%, at the company's election
Covenants include a maximum net leverage ratio of 3.50 to 1.00, and secured liens on substantially all domestic assets that are released upon an investment grade period
No amounts outstanding under the facility as of October 15, 2026
Compass Minerals disclosed that director David Safran resigned on October 9, 2026, and the board accepted the resignation on October 14. The board then reduced its size to eight members, the filing says. The filing contains no financial figures or stated reason for the resignation.
David Safran delivered his resignation as a director on October 9, 2026.
The Board voted to accept the resignation on October 14, 2026.
On October 14, 2026, the Board voted to reduce its size to eight members.
As of October 13, 2026, United States Natural Gas Fund, LP amended its ISDA 2002 Master Agreement with Société Générale, lowering the Total Net Assets Decline Event termination trigger from $1.5 billion to $200 million. The company says the reduced threshold reflects its performance and is intended to ensure the trigger is not hit absent a credit event.
Amendment dated as of October 13, 2026 to the ISDA 2002 Master Agreement originally entered into June 13, 2022
TNA Decline Event Additional Termination Event threshold reduced from $1.5 billion to $200 million
Full agreement filed as Exhibit 10.16 and incorporated by reference
Mesabi Trust's trustees said no distribution has been declared this quarter and none will be paid in November 2026, compared with $0.34 per Unit declared for the same period last year. The trustees cited a July 30, 2026 royalty payment of $1,807,779 from Cleveland-Cliffs, which included no bonus royalty and was below the $5,300,287 received in July 2025, leaving unitholders with no quarterly payout.
No distribution declared this quarter and none to be paid in November 2026, versus $0.34 per Unit a year earlier
July 30, 2026 royalty payments from Cleveland-Cliffs totaled $1,807,779, with no bonus royalty, compared with $5,300,287 in July 2025
Cliffs reported zero bonus royalties in each 2026 quarterly report, with Silver Bay shipments priced below the $71.70 per ton threshold
Third-quarter royalty payments are due October 30, 2026, with a summary to be filed on Form 8-K afterward
Datavault AI appointed Jeffrey Tirman to its board, effective October 12, 2026, filling the seat vacated by Wendy Wilson's resignation. NYIAX designated Tirman under the Merger Agreement for its acquisition by the company, and the filing says Wilson resigned to allow that appointment, not due to any disagreement. Tirman's appointment ties board composition to the NYIAX deal, and he holds 26 million DVLT shares through his family office.
Wendy Wilson resigned from the board on October 11, 2026, effective October 12, 2026; the filing says this was not due to any disagreement.
Jeffrey Tirman was appointed to the board on October 11, 2026, effective after Wilson's resignation, and was designated by NYIAX under the Merger Agreement.
Tirman holds 26 million DVLT shares through Abri Capital Ltd., according to the press release.
As a non-employee director, Tirman receives $60,000 per year in cash compensation and a 125,000-share restricted stock award under the 2018 Plan, subject to an S-8 registration statement.
Amplitude appointed Vijaye Raji, founder and former CEO of Statsig and CTO of Applications at OpenAI, as a Class III director effective October 15, 2026, filling a newly created seat that expands the board from eight to nine members. The filing discloses his compensation and a planned indemnification agreement, and it does not report any financial results or change in guidance.
Board expanded from eight to nine directors; Raji named to Cybersecurity Committee
Annual cash retainer of $30,000 for board service plus $4,000 for Cybersecurity Committee service
Initial RSU award of $525,000 vesting in thirds on each grant anniversary; annual RSU award of $175,000
On October 14, 2026, Crescent Energy Finance LLC signed a sixteenth amendment to its credit agreement that permits the previously announced acquisition of Eagle Ford assets from a Devon Energy subsidiary and allows up to $2.0 billion of unsecured bridge debt to help fund part of the cash price. The company also said it expects cash paid on commodity derivatives of $144 million for the third quarter and $383 million for the first nine months of 2026, both preliminary. The filing does not state the acquisition price, so shareholders can't yet gauge the deal's scale relative to the new debt.
Sixteenth Amendment dated October 14, 2026 permits the Devon EF Assets Acquisition from Devon Energy Production Company, L.P.
Permits an up to $2.0 billion 364-day unsecured bridge credit facility to fund part of the cash consideration.
Permits additional pari passu secured term loan debt, capped at the lesser of a borrowing base formula and 50.0% of total elected commitments plus permitted pari passu debt.
Expected cash paid on commodity derivatives: $144 million for Q3 2026 and $383 million for nine months ended September 30, 2026.
Simmons First National Corporation reported third quarter 2026 net income of $47.1 million, or $0.32 diluted EPS, down from $66.7 million and $0.46 in the second quarter of 2026, while total revenue rose to $251.2 million from $248.6 million. Adjusted diluted EPS rose to $0.54 from $0.50, excluding $43.2 million in pre-tax items such as branch rightsizing, severance and certain professional services costs. For shareholders, GAAP earnings declined while adjusted earnings and net interest margin improved, and management plans to outline future financial targets at an Investor Day in December.
Net income $47.1 million in 3Q26 vs $66.7 million in 2Q26; diluted EPS $0.32 vs $0.46
Adjusted diluted EPS $0.54 vs $0.50 in 2Q26; certain items totaled $43.2 million pre-tax
Net interest margin rose 8 basis points to 3.92%; total deposits fell to $18.6 billion from $19.7 billion
Nonperforming loans rose to $179.9 million from $166.1 million; about $161 million remains under the 2026 buyback program, with no repurchases in the quarter
Four Greenlane Holdings subsidiaries executed assignments for the benefit of creditors on September 30, 2026, with Philip J. von Kahle as assignee, who will liquidate their assets and distribute proceeds to creditors under Florida law. The Court in Miami-Dade County assumed jurisdiction over the assets on October 9, 2026, and the filing notes the related deconsolidation of these subsidiaries and possible claims against the Company, so shareholders face the risk of losing value tied to these businesses.
Four subsidiaries assigned to Philip J. von Kahle on September 30, 2026: Warehouse Goods LLC, Greenlane Holdings, LLC, KIM International, LLC and Kush Supply Co. LLC
Petitions filed October 9, 2026 in Circuit Court of the Eleventh Judicial Circuit, Miami-Dade County, Complex Business Division
Proceedings not yet consolidated and no judge assigned as of the filing date; assignments do not release the subsidiaries from their liabilities
First Tracks Biotherapeutics agreed on October 15, 2026 to sell 6,106,870 common shares at $32.75 each to institutional investors, for expected gross proceeds of about $200 million before placement fees and expenses. The deal is expected to close on October 19, 2026, and proceeds will fund general corporate purposes, including clinical development of ANB033. The new shares are unregistered and will be issued to investors who must be covered by a resale registration statement filed within 30 days after closing, so existing shareholders face dilution from the issuance and possible future resales.
Sale of 6,106,870 common shares at $32.75 per share, for about $200 million in gross proceeds before fees and expenses
Expected closing on October 19, 2026, subject to customary conditions
Placement agents are Leerink Partners, Piper Sandler, UBS Investment Bank and Wells Fargo Securities
Company had 35,909,814 common shares outstanding as of October 12, 2026; resale registration due within 30 days after closing
On October 14, 2026, FreightCar America entered a Stockholder Agreement with three OC III entities that collectively own about 48.8% of its common stock, including warrants. The company also amended and terminated its August 5, 2026 Rights Agreement, so the rights expired at the close of business that day and common holders no longer hold rights under the plan.
OC III entities collectively own about 48.8% of common stock, including warrants, per a July 2, 2026 Schedule 13D/A
Rights Agreement dated August 5, 2026 was amended to accelerate expiration from July 5, 2027 to close of business October 14, 2026
Board must review transfers of shares to any holder above 20%; agreement ends at the earlier of the fourth anniversary or when the group falls to 20% or less
Company agreed not to adopt future rights plans with an ownership trigger below 20%
Crescent Biopharma said in an October 15, 2026 press release that it has enrolled patients in chemotherapy combination cohorts of its ASCEND trial for CR-001, and that the FDA has cleared its CR-002 ADC for a Phase 1/2 trial. The filing gives timing for several clinical data readouts but reports no revenue, earnings, or financial results, so it is a pipeline update rather than a financial report for shareholders.
Initial CR-001 monotherapy data from ASCEND expected in the first quarter of 2027, covering more than 125 patients
Chemotherapy combination cohort data anticipated in mid-2027; Phase 3 trials of CR-001 planned to start in early 2028
CR-002 received FDA IND clearance in October 2026; APOLLO Phase 1/2 trial planned to start in the fourth quarter of 2026, with initial data in the second half of 2027
Daily Journal Corporation completed its acquisition of Revir Technologies, Inc., an Austin, Texas software company behind the Scout AI platform for managing digital evidence, on October 13, 2026, using cash on hand. The company says the deal is not material to its financial condition or results, and financial terms were not disclosed.
Acquisition closed October 13, 2026 via merger of a wholly owned subsidiary into Revir
Revir will operate independently within the new Courts, Justice, and Government Technology division alongside Journal Technologies
Funded with cash on hand; financial terms were not disclosed and the company says it is not material
Cohen & Steers reported third-quarter 2026 revenue of $157.4 million, up about 3% from the second quarter and about 11% from a year earlier, driven by higher average AUM. GAAP diluted EPS was $0.81, down from $0.95 in the second quarter and flat year over year, while adjusted diluted EPS rose to $0.89 from $0.85. AUM ended the quarter at $95.9 billion, down 4.2% from $100.1 billion, as market depreciation of $5.1 billion outweighed net inflows of $1.6 billion.
Revenue: $157.4 million, up about 3% from $152.7 million in Q2 2026 and about 11% from $141.7 million in Q3 2025
GAAP diluted EPS $0.81 vs. $0.95 in Q2 2026 and $0.81 in Q3 2025; adjusted diluted EPS $0.89 vs. $0.85 in Q2 2026
AUM $95.9 billion at September 30, 2026, down from $100.1 billion at June 30, 2026, with net inflows of $1.6 billion
Board declared a $0.67 quarterly dividend per share, paid August 20, 2026
Frazier Life Sciences Acquisition Corp. II, a special purpose acquisition company, closed its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share on October 15, 2026, raising $75 million in gross proceeds. The company also sold 300,000 private placement shares to its sponsor for $3 million, and $75 million of the proceeds was placed in a trust account for public shareholders, who can only access it through a business combination or redemption, with a 24-month deadline from the IPO closing.
IPO of 7,500,000 Class A ordinary shares at $10.00 per share closed October 15, 2026, for gross proceeds of $75 million; shares trade on Nasdaq Capital Market under FLSC
Sponsor Frazier Life Sciences Holdings II, LLC bought 300,000 private placement shares at $10.00 each, for $3 million
$75 million placed in trust account held by Continental Stock Transfer & Trust Company; company has 24 months from IPO closing to complete an initial business combination
Frazier Life Sciences Public Fund, L.P. committed to buy at least 2,500,000 Class A shares at $10.00 each, a minimum of $25 million, at the closing of a business combination
Avnet and Avnet Holding Europe BV signed Amendment No. 3 to the company's credit agreement on October 13, 2026, with Bank of America, N.A. as administrative agent. The amendment increases total commitments by $1.0 billion to $2.75 billion and raises the maximum additional commitments the company can request to $1.0 billion. For shareholders, it expands the company's available borrowing capacity under the facility, and the filing states that other terms remain substantially the same.
Total commitments under the credit agreement increase by $1.0 billion to $2.75 billion.
Maximum additional commitments the company can request rise to $1.0 billion.
The SOFR credit spread adjustment to the interest rate is eliminated.
The amendment is dated October 13, 2026 and is filed as Exhibit 10.1; the original agreement is dated January 17, 2025.
J.B. Hunt Transport Services reported third quarter 2026 results for the period ended September 30, 2026, with total operating revenue up 20% to $3.68 billion and diluted earnings per share of $1.82 versus $1.76 a year earlier. Operating income rose 2% to $247.1 million, but operating income as a percentage of gross revenue declined, and the company cited higher purchased transportation, fuel costs and insurance claims.
Q3 2026 total operating revenue was $3.68 billion, up 20%; revenue excluding fuel surcharge rose 13%.
Net earnings were $172.4 million versus $170.8 million a year earlier; diluted EPS was $1.82 versus $1.76.
Operating income was $247.1 million, up 2%; Dedicated Contract Services operating income fell 22% to $81.7 million.
In the third quarter the company bought back about 704,000 shares for about $174 million and had about $619 million left under its repurchase authorization.
Prudential disclosed preliminary, unaudited third-quarter 2026 figures ahead of its November 3, 2026 earnings release, showing an estimated $140 million reduction in Japan Businesses pre-tax adjusted operating income from the Prudential of Japan sales suspension. The company also estimated alternative investment income of its General Account $15 million to $35 million above near-term expectations, and it reclassified its International Businesses segment as Japan Businesses effective the third quarter of 2026. The figures are not final and financial closing procedures are not complete.
Prudential of Japan sales suspension estimated to reduce Japan Businesses pre-tax adjusted operating income by about $140 million in the quarter ended September 30, 2026, including one-time costs
General Account alternative investment income estimated at $15 million to $35 million above near-term expectations for the quarter
PGIM assets under management were $1.47 trillion as of September 30, 2026; PGIM other related revenues were about $20 million on an adjusted operating income basis
Brazil and Mexico operations moved to Divested and Run-off Businesses; AFP Habitat moved to Retirement; revised second quarter 2026 supplement furnished as Exhibit 99.1
New America Acquisition I Corp. entered into an Administrative Services Agreement with Dominari Holdings Inc., an affiliate of certain officers and directors, for office space and administrative services at $20,000 per month. On the same day, the company's earlier administrative services agreement with its sponsor, New America Sponsor I LLC, was terminated under a Termination and Release Agreement.
New agreement with Dominari Holdings Inc. dated October 15, 2026, at $20,000 per month
Fee runs until the earlier of an initial business combination or the company's liquidation
Prior administrative services agreement with New America Sponsor I LLC, dated December 3, 2025, terminated October 15, 2026
Halliburton's Board appointed David C. Hernandez, president of Hunt Consolidated, as a director on October 15, 2026, filling a vacancy and keeping the Board at 12 members. The appointment also shifts committee seats, moving Timothy A. Leach from the Audit Committee to the Compensation Committee, and gives Hernandez an initial award of 961 restricted stock units.
Hernandez joins the Board on October 15, 2026 and is appointed to the Audit Committee and the Health, Safety and Environment Committee.
The Board has determined Hernandez is independent under NYSE listing standards and designated him an audit committee financial expert.
Timothy A. Leach moves from the Audit Committee to the Compensation Committee.
Hernandez receives an initial award of 961 restricted stock units and entered into an indemnification agreement with Halliburton on October 15, 2026.
BJ's Wholesale Club Holdings promoted Bill Werner to Executive Vice President, Chief Development Officer, effective October 8, 2026, adding business-to-business operations to his real estate and fuel responsibilities, and raised his annual base salary to $800,000. The filing also discloses one-time awards approved on September 22, 2026 for Chief Financial Officer Laura Felice and Mr. Werner in recognition of the resolution of credit card interchange fee litigation in which the company was a plaintiff.
Werner promoted effective October 8, 2026 to Executive Vice President, Chief Development Officer
Annual base salary increased to $800,000; his employment agreement dated May 10, 2021 remains unchanged
September 22, 2026 one-time awards: Felice $250,000 cash; Werner $500,000 cash plus RSUs with a $500,000 grant-date value, granted September 30, 2026 and vesting on the second anniversary
Blue Owl Finance LLC, an indirect subsidiary of Blue Owl Capital Inc., signed a fourth amendment to its credit agreement on October 14, 2026. The revolving credit commitment rises to $3,225,000,000 (potentially $3,870,000,000 if conditions are met), the maturity is extended to October 14, 2031, and pricing is reduced, which lowers borrowing costs for the subsidiary.
Revolving commitment increased to $3.225 billion, with a potential increase to $3.87 billion if conditions are satisfied
Maturity extended from the existing date to October 14, 2031
Term SOFR loan margin reduced to 77.5 to 127.5 basis points; commitment fee rate reduced to 7.0 to 16.5 basis points
MUFG Bank, Ltd. serves as administrative agent; the Company itself is not a party to the amended agreement
Medline Inc. disclosed that director Joseph P. Baratta notified the Board on October 13, 2026 that he will resign, effective December 31, 2026. The company said the decision coincides with his previously announced departure from Blackstone Inc. and is not due to any disagreement over company operations, policies, or practices.
Joseph P. Baratta notified the Board on October 13, 2026 of his decision to resign.
Resignation is effective December 31, 2026.
Company states there was no disagreement with management related to operations, policies, or practices.
Filing was signed by Chief Legal Officer Alex M. Liberman on October 15, 2026.
On October 15, 2026, subsidiary NCL Corporation closed a $950.0 million offering of 8.750% senior notes due 2031, with net proceeds of approximately $941.7 million. The company used the proceeds, with cash on hand, to redeem its 6.125% notes due 2028 and to repay and prepay other borrowings, and it amended its revolving credit facility to raise lender commitments to $2,801.0 million. For shareholders, the filing shows a debt refinancing and a larger revolver, but the new notes carry a higher interest rate than the notes they replaced.
$950.0 million of 8.750% senior notes due October 15, 2031 closed October 15, 2026; net proceeds approximately $941.7 million before estimated fees and expenses.
Proceeds, with cash on hand, used to redeem all outstanding 6.125% notes due 2028 and to repay approximately $376.3 million of revolver borrowings and prepay approximately $42.2 million of export-credit facilities.
Revolving loan commitments increased from $2,486.0 million to $2,801.0 million; maturity is January 22, 2030, subject to conditions tied to 2027 exchangeable notes.
Pride of America Ship Holding and Norwegian Epic were added as guarantors; Norwegian Dawn and Norwegian Spirit were released as guarantors.
The Charles Schwab Corporation reported third-quarter 2026 results for the quarter ended September 30, 2026, in an 8-K furnishing its earnings press release as Exhibit 99.1. Net revenues rose 17% year-over-year to a record $7.2 billion, and GAAP diluted earnings per share rose 29% to $1.62 from $1.26. The results show growth in both revenue and profit, while GAAP results include $151 million of pre-tax transaction-related costs that the company excluded from its adjusted figures.
Net income was $2.9 billion for the quarter, up 23% from $2.4 billion a year earlier; adjusted diluted EPS was $1.69.
Core net new assets were $190.4 billion, up 38% versus the third quarter of 2025.
Pre-tax transaction-related costs totaled $151 million; the company also hosted a Fall Business Update for institutional investors on October 15, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.